1. Boyer S, Muthas D, Greene N (2012) Information, informatics and modeling predictive toxicology. In: Wilson AGE (ed) New horizons in predictive toxicology: current status and application. Royal Society of Chemistry, London, pp 70–100
2. EMA (2009) Assessment of genotoxic impurities:
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002903.pdf
3. FDA (2009) Assessment of genotoxic impurities:
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079235.pdf
,
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002907.pdf
4. Glowienke S, Hasselgren C (2010) Use of structure activity relationship (SAR) evaluations as a critical tool in the evaluation of the genotoxic potential of impurities. In: Teasdale A (ed) Genotoxic impurities: strategies for identification and control. Wiley, New York, pp 97–120
5. Hasselgren C, Muthas D, Ahlberg E, Andersson S, Carlsson L, Noeske T, Stålring J, Boyer S (2013) Chemoinformatics and beyond – moving from simple models to complex relationships in pharmaceutical computational toxicology. In: Bajorath J (ed) Chemoinformatics: case studies and pharmaceutical applications. Wiley, New York, pp 49–62